K
Kailashwanti
About Kailashwanti
Data last updated:
Kailashwanti is a Director at Asian Oncocare Private Limited (since 2014) and Designated Partner at Global Oncocare Hospital & Research Centre Llp (since 2017). The companies operate in Healthcare, Pharma and Internet. The largest current company by reported revenue is Asian Oncocare Private Limited at ₹1.61 Cr (FY 2016). Earlier, Kailashwanti was a Designated Partner at Janvi Health Care Solutions Llp (2019–2020) and Designated Partner at Asian Oncocare Research Centre Llp (from 2016).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Asian Oncocare Private Limited U74900RJ2014PTC045981 | Director | 28 Jul 2014 | 2014 | ₹1.61 Cr (FY 2016) | Active |
| Designated Partner | 10 Jul 2017 | 2017 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Janvi Health Care Solutions Llp AAO-2314 | Designated Partner | 07 Feb 2019 | 2019 | ₹70.1 Lakh (FY 2023) | Active |
| Asian Oncocare Research Centre Llp AAH-4397 | Designated Partner | 20 Sep 2016 | 2016 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Kailashwanti
| Name | DIN | Company | Designation |
|---|---|---|---|
| Satpal Singh | 07855160 | Asian Oncocare Private Limited , Global Oncocare Hospital & Research Centre Llp | Director |
| Shayna Monga | 08211741 | Global Oncocare Hospital & Research Centre Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Kailashwanti
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kailashwanti
Kailashwanti currently holds 2 directorships: Asian Oncocare Private Limited (Director, since 28 Jul 2014, revenue ₹1.61 Cr (FY 2016)); Global Oncocare Hospital & Research Centre Llp (Designated Partner, since 10 Jul 2017).
Kailashwanti was first appointed on 28 Jul 2014 as Director at Asian Oncocare Private Limited. The most recent appointment on record is 07 Feb 2019 at Janvi Health Care Solutions Llp.
Kailashwanti held 2 earlier board appointments: Janvi Health Care Solutions Llp (Designated Partner, 07 Feb 2019 to 21 Feb 2020); Asian Oncocare Research Centre Llp (Designated Partner, from 20 Sep 2016).
The current boards of Kailashwanti's companies include Satpal Singh (Asian Oncocare Private Limited), Shayna Monga (Global Oncocare Hospital & Research Centre Llp).